Technology | January 03, 2013

Azure Cloud Platform Enables Availability of Volpara Objective Breast Density Measurement via the Cloud

Matakina International today announced a partnership with Microsoft Corporation to make its revolutionary breast density assessment software available to users globally via the Microsoft Azure Cloud. As a result of the partnership, the company launched a cloud-based version of its Volpara Breast Density Assessment software at the 98th annual meeting of the Radiology Society of North America, Nov. 25-30, 2012.

Cleared by the Federal Drug Administration (FDA), HealthCanada, the TGA and CE-marked, Volpara is in use at sites across the globe helping radiologists assess breast density more objectively and helping them better consider who might benefit from additional screening. 

Until now, Volpara has been installed on individual workstations or as an enterprise-wide solution where the software is installed on a central server. Driven by use of Volpara in a number of large clinical trials and national breast cancer screening programs worldwide, the additional cloud-based option now offers secure, HIPAA-compliant access to the raw mammography acquisition data required to perform breast density assessment. And, for the first time, the cloud-based version also enables facilities and researchers to store unlimited data.

“The cloud also enables the ability to perform temporal analysis of breast density. Traditionally, facilities have not stored the raw data from which density measurement is performed. Now with long-term secure access to breast density data, an individual patient’s breast density values from one year could be compared with other years, which we believe could help detect cancers earlier by picking up the first signs of change,” said Prof. Martin Yaffe, professor of biomedical physics at the University of Toronto and one of the founders of Matakina.

Volpara is a reliable tool which generates objective, automatic measurement of volumetric breast density values under the Volpara Density Grade (VDG) – a refined grading system which correlates with the American College of Radiology BIRADS Density Grading Classifications. Volpara is FDA cleared for all digital mammography units; integration with other digital mammography systems, computer-aided detection (CAD) systems and mammography reporting systems are also underway.

For more information:

Related Content

Clinical Trial Testing Topical Gel to Reduce Breast Density
News | Breast Density | June 19, 2018
Women with dense breast tissue soon might be adding a new product to their skincare routine to help them fight breast...
California Women In Favor of Extending State's Breast Density Inform Law
News | Breast Density | June 15, 2018
A recent survey of California women found that 95 percent of respondents want the state’s breast density inform law to...
Women More Likely to Use Other Preventive Health Services Following Mammography
News | Mammography | June 13, 2018
Medicare beneficiaries who undergo breast cancer screening with mammography are more likely than unscreened women to...
Breast imaging technologies have seen a rapid evolution.

Breast imaging technologies have seen a rapid evolution.

Feature | Women's Health | June 05, 2018 | By Jeff Zagoudis
Breast imaging technologies have evolved rapidly in the last two decades to help physicians detect breast cancers at
Breast Cancer Survivors Not Getting Recommended Number of Mammograms Post-Surgery
News | Mammography | May 24, 2018
Breast cancer survivors are not getting the recommended level of screening post-surgery, according to a newly-published...
FDA's MQSA Accreditation Bodies Approved for Tomosynthesis Accreditation

Image courtesy of Fujifilm.

Feature | Mammography | May 14, 2018
On April 9, 2018, the U.S. Food and Drug Administration (FDA) announced that all four of its Mammography Quality...
Videos | Breast Imaging | May 08, 2018
ITN Associate Editor Jeff Zagoudis speaks with Karen Hou, M.D., breast radiologist at Northwestern Medicine Central D
Computer Error Leads to 450,000 Missed U.K. Breast Screening Invites
News | Mammography | May 02, 2018
Since 2009, approximately 450,000 women around age 70 in the United Kingdom did not receive final breast screening...
Pilot Study Initiated for Blood-Based Breast Test
News | Oncology Diagnostics | May 01, 2018
Overlake Medical Center in Bellevue, Wash., announced it has enrolled 85 patients in a pilot study of a blood test to...
Overlay Init